As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

This week the Advisory Committee on Immunization Practices (ACIP) will consider delaying the infant hepatitis B (HepB) birth ...

A new review of more than 400 studies spanning 40 years finds no evidence that delaying the universal hepatitis B vaccine ...

Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the ...

A University of Minnesota-led review is urging federal health advisers to maintain a longstanding immunization strategy that ...

The hepatitis B virus infects around 250 million people worldwide, and is transmitted through blood and bodily fluids. It is commonly transferred from mother to baby during birth. However the virus ...

Delaying the timing of vaccinating infants against hepatitis B — which ACIP could vote on later this week — would likely lead ...

Hepatitis B poses health risks for pregnant people and their babies. These include virus transmission from parent to newborn, preterm labor, and hepatitis B complications in pregnant people. Testing ...

Chronic hepatitis B occurs when the body cannot eliminate the hepatitis B virus following an acute infection. Having chronic (or lifelong) hepatitis B can increase a person’s risk of developing ...

The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved ...

If someone presents you with a hepatitis B declination form, you might have some questions about it and the hepatitis B vaccine more generally. Hepatitis B is an infection of the liver due to the ...